HomeInsightsStock Comparison

Dr Lal Pathlabs Ltd vs Global Health Ltd Stock Comparison

Dr Lal Pathlabs Ltd vs Global Health Ltd Stock Comparison

Last Updated on: May 20, 2025

Key Highlights

  • The Latest Trading Price of Dr Lal Pathlabs Ltd is ₹ 2825 as of 20 May 09:04.
  • The P/E Ratio of Dr Lal Pathlabs Ltd changed from 51.7 on March 2020 to 52.8 on March 2024 . This represents a CAGR of 0.42% over 5 yearsThe P/E Ratio of Global Health Ltd changed from 43.3 on March 2023 to 0 on March 2024 . This represents a CAGR of -100.00% over 2 years.
  • The Market Cap of Dr Lal Pathlabs Ltd changed from ₹ 11679 crore on March 2020 to ₹ 18888 crore on March 2024 . This represents a CAGR of 10.09% over 5 yearsThe Market Cap of Global Health Ltd changed from ₹ 14111 crore on March 2023 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 2 years.
  • The revenue of Dr Lal Pathlabs Ltd for the Mar '25 is ₹ 628.4 crore as compare to the Dec '24 revenue of ₹ 621.8 crore. This represent the growth of 1.06% The revenue of Global Health Ltd for the Mar '25 is ₹ 954.18 crore as compare to the Dec '24 revenue of ₹ 959.46 crore. This represent the decline of -0.55%.
  • The ebitda of Dr Lal Pathlabs Ltd for the Mar '25 is ₹ 194.8 crore as compare to the Dec '24 ebitda of ₹ 179.1 crore. This represent the growth of 8.77% The ebitda of Global Health Ltd for the Mar '25 is ₹ 197.72 crore as compare to the Dec '24 ebitda of ₹ 253.79 crore. This represent the decline of -22.09%.
  • The net profit of Dr Lal Pathlabs Ltd changed from ₹ 83.6 crore to ₹ 155.5 crore over 8 quarters. This represents a CAGR of 36.38% The net profit of Global Health Ltd changed from ₹ 102.01 crore to ₹ 101.38 crore over 8 quarters. This represents a CAGR of -0.31% .
  • The Dividend Payout of Dr Lal Pathlabs Ltd changed from 49.24 % on March 2020 to 39.09 % on March 2024 . This represents a CAGR of -4.51% over 5 yearsThe Dividend Payout of Global Health Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dr Lal Pathlabs Ltd

  • Dr. Lal PathLabs Limited was incorporated as a Private Limited Company with the name Dr. Lal PathLabs Private Limited', on February 14, 1995 at Delhi.
  • The business of the Partnership Firm, Central Clinical Laboratory was undertaken by the Company.
  • The Company converted into a Public Limited Company and name of the Company was changed to Dr. Lal PathLabs Limited' vide fresh Certificate of Incorporation granted by the RoC on August 19, 2015. Dr Lal PathLabs is among the most trusted diagnostic healthcare service provider in India, offering services through over 5000 diagnostic tests and related healthcare services through a nationwide network of medical laboratory centres.
  • Through its integrated, nationwide network, the Company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Global Health Ltd

  • Global Health Limited (GHL) was incorporated as Global Health Private Limited' on August 13, 2004 at New Delhi, India as a Private Limited Company.
  • The Company got converted into a Public Limited Company and name of the Company was changed to Global Health Limited' dated August 11, 2021 issued by the RoC. Presently, the Company is engaged in providing healthcare services. The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon.
  • The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly.

Dr Lal Pathlabs Ltd News Hub

News

Board of Dr. Lal PathLabs recommends final dividend

Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held ...

Read more

25 Apr 2025 15:23

News

Dr. Lal PathLabs to convene AGM

Dr. Lal PathLabs announced that the Annual General Meeting(AGM) of the company will be hel...

Read more

25 Apr 2025 15:23

News

Dr. Lal PathLabs schedules board meeting

Dr. Lal PathLabs will hold a meeting of the Board of Directors of the Company on 25 April ...

Read more

19 Apr 2025 10:39

News

Dr Lal Pathlabs introduces highly specialized Amyloidosis test

Dr Lal Pathlabs has introduced Amyloid Typing by Laser Capture Microdissection & Mass Spec...

Read more

15 Apr 2025 14:09

News

Dr Lal Pathlabs Ltd leads losers in 'A' group

Aditya Birla Real Estate Ltd, Can Fin Homes Ltd, Paisalo Digital Ltd and Religare Enterpri...

Read more

25 Feb 2025 15:00

News

Dr Lal Pathlabs allots 4,000 equity shares under ESOP

Dr Lal Pathlabs has allotted 4,000 equity shares under ESOP on 18 February 2025. With this...

Read more

18 Feb 2025 18:20

Global Health Ltd News Hub

News

Board of Global Health recommends final dividend

Global Health announced that the Board of Directors of the Company at its meeting held on ...

Read more

15 May 2025 16:58

News

Global Health allots 73,000 equity shares under ESOP

Global Health has allotted 73,000 equity shares to GHL Employee Welfare Trust ('ESOP Trust...

Read more

15 May 2025 12:07

News

Global Health to table results

Global Health will hold a meeting of the Board of Directors of the Company on 15 May 2025....

Read more

05 May 2025 13:58

News

Global Health to set up 400-bed super specialty hospital in North East

Global Health 'Medanta' announced its entry into the North East with its plan to establish...

Read more

28 Apr 2025 17:26

News

Global Health grants 5.85 lakh options and offers 2.03 lakh shares under LTIP 2024 Plan

Global Health has approved the grant of 5,85,500 Options and Offer of 2,03,000 Shares to c...

Read more

08 Apr 2025 13:27

News

Global Health receives land offer from Assam Government for super speciality hospital

The company intends to develop a super speciality hospital on this land. Global Health ope...

Read more

08 Apr 2025 10:51

SWOT Analysis Of Global Health Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Dr Lal Pathlabs Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Global Health Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Dr Lal Pathlabs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dr Lal Pathlabs Ltd and Global Health Ltd

Which company has a larger market capitalization, Dr Lal Pathlabs Ltd or Global Health Ltd?

Market cap of Dr Lal Pathlabs Ltd is 23,365 Cr while Market cap of Global Health Ltd is 31,768 Cr

What are the key factors driving the stock performance of Dr Lal Pathlabs Ltd and Global Health Ltd?

The stock performance of Dr Lal Pathlabs Ltd and Global Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lal Pathlabs Ltd and Global Health Ltd?

As of May 20, 2025, the Dr Lal Pathlabs Ltd stock price is INR ₹2795.2. On the other hand, Global Health Ltd stock price is INR ₹1182.8.

How do dividend payouts of Dr Lal Pathlabs Ltd and Global Health Ltd compare?

To compare the dividend payouts of Dr Lal Pathlabs Ltd and Global Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions